Top Section/Ad
Top Section/Ad
Most recent
The rollover risks sovereigns are accepting in exchange for cheaper funding
It's not the juniors in capital markets who need protecting from obsolescence. They stand to benefit most from the deployment of AI
Investors and techniques are ready for development banks to scale up securitization rapidly
Risks in exchange-traded funds holding CLOs are real, but there could be scope to relax the rules
More articles/Ad
More articles/Ad
More articles
-
The European loan market’s pulse is quickening after 18 months of painful rehabilitation. But there is a real danger that the market’s return to full health might take longer than it should as borrowers wait for margins to fall further before making the (re)financing leap.
-
The Bank of England’s broad conception of transparency, revealed in a consultation on ABS eligibility criteria, is refreshing in a world where everyone is looking for a silver bullet.
-
Germany’s Merck KGaA’s Eu3.2bn bond came under fire last week for what some described as overly generous pricing. But this wasn’t an exercise in setting price benchmarks. Surety of funds has to be the main concern in any acquisition-related funding, and in that respect, Merck’s strategy was spot on.
-
The European loan market’s pulse is quickening after 18 months of painful rehabilitation. But there is a real danger that the market’s return to full health might take longer than it should as borrowers wait for margins to fall further before making the (re)financing leap.
-
The Middle East’s loan market has had a good start to 2010. But there is still some way to go before calling a full recovery. Luckily, for some sectors at least, the bond market is proving a reliable alternative source of funding.
-
Rouble Eurobonds from Russian issuers — the emerging market’s bull market product of 2007 — are back. And this time, they could be here to stay.